Comparative role of intravitreal ranibizumab versus bevacizumab in choroidal neovascular membrane in age-related macular degeneration

CONTEXT: Ranibizumab and bevacizumab are used widely for treating patients with choroidal neovascular membrane (CNVM) secondary to age-related macular degeneration (AMD). AIMS: To determine and compare the efficacy and safety of intravitreal ranibizumab and bevacizumab in treatment of CNVM due to AM...

Descripción completa

Detalles Bibliográficos
Autores principales: Biswas, Partha, Sengupta, Subhrangshu, Choudhary, Ruby, Home, Subhankar, Paul, Ajoy, Sinha, Sourav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120237/
https://www.ncbi.nlm.nih.gov/pubmed/21586838
http://dx.doi.org/10.4103/0301-4738.81023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120237/
https://www.ncbi.nlm.nih.gov/pubmed/21586838
http://dx.doi.org/10.4103/0301-4738.81023

Ejemplares similares